Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study
Cosmi, B.; Palareti, G.; Moia, M.; Pengo, V.; Testa, S.
Minerva Cardioangiologica 47(12): 598-599
1999
ISSN/ISBN: 0026-4725 PMID: 10670221 Document Number: 508532
Document emailed within 1 workday
Related Documents
Poller, L.; Keown, M.; Chauhan, N.; Shiach, C.; van den Besselaar, A.M.H.P.; Tripodi, A.; Jespersen, J. 2002: European Concerted Action on Anticoagulation (ECAA): International Normalized Ratio variability of CoaguChek and TAS point-of-care testing whole blood prothrombin time monitors Thrombosis and Haemostasis 88(6): 992-995Van Wijk, E.M.; Kahlé, L.H.; ten Cate, J.W. 1980: Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants Clinical Chemistry 26(7): 885-890
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Vibhagool, A.; Sungkanuparph, S.; Mootsikapun, P.; Chetchotisakd, P.; Tansuphaswaswadikul, S.; Bowonwatanuwong, C.; Ingsathit, A. 2003: Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 36(10): 1329-1331
Shapiro, B.A.; Mahutte, C.K.; Cane, R.D.; Gilmour, I.J. 1993: Clinical performance of a blood gas monitor: a prospective, multicenter trial Critical Care Medicine 21(4): 487-494
Hashizume, K.; Kawai, K.; Kane, N.; Fukuda, R.; Matsubara, F. 1973: Studies on determination of partial thromboplastin time and prothrombin time using BBL fibrometer Rinsho Byori. Japanese Journal of Clinical Pathology 21(8): 721-724
Passeron, J.; Guillet, C. 1992: Treatment with rilmenidine 1 mg per day: time-lag to maximum response. a multicenter ambulatory study. le Groupe Français d'étude Multicentrique d'Hyperium Presse Medicale 21(43): 2089-2093
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Haller, M.; Zöllner, C.; Briegel, J.; Forst, H. 1995: Evaluation of a new continuous thermodilution cardiac output monitor in critically ill patients: a prospective criterion standard study Critical Care Medicine 23(5): 860-866
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Aghajanian, A.; Grimes, D.A. 1991: Routine prothrombin time determination before elective gynecologic operations Obstetrics and Gynecology 78(5 Part 1): 837-839
Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Namisango, E.; Harding, R.; Atuhaire, L.; Ddungu, H.; Katabira, E.; Muwanika, F.R.; Powell, R.A. 2012: Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect Journal of Pain 13(7): 704-713
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Lu, K.H.; Loose, D.S.; Yates, M.S.; Nogueras-Gonzalez, G.M.; Munsell, M.F.; Chen, L-May.; Lynch, H.; Cornelison, T.; Boyd-Rogers, S.; Rubin, M.; Daniels, M.S.; Conrad, P.; Milbourne, A.; Gershenson, D.M.; Broaddus, R.R. 2013: Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome Cancer Prevention Research 6(8): 774-781
Erpenbach, K.; Miller, K. 1992: Prospective randomized multicenter phase IIB study in patients with mumps orchitis Der Urologe. Ausg. a 31(5): 317-318
Pérez-Contreras, J.; Miguel, A.; Sánchez, J.; Rivera, F.; Olivares, J. 2000: A prospective multicenter comparison of peritonitis in peritoneal dialysis patients aged above and below 65 years. Levante PD Multicenter Group Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 16: 267-270
Rawdaree, P.; Sarinnapakorn, V.; Pattanaungkul, S.; Khovidhunkit, W.; Tannirandorn, P.; Peerapatdit, T. 2014: A prospective, longitudinal, multicenter, observational study to assess insulin treatment patterns in diabetic patients in Thailand: results from the TITAN Study Journal of the Medical Association of Thailand 97(11): 1140-1150
Nguyen, M.H.; Peacock, J.E.; Tanner, D.C.; Morris, A.J.; Nguyen, M.L.; Snydman, D.R.; Wagener, M.M.; Yu, V.L. 1995: Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study Archives of Internal Medicine 155(22): 2429-2435